Methadone Dosing for Pain Control

Initial Dosing and Titration

Methadone should be initiated at low doses (2.5-5 mg every 8 hours or 5-10 mg total daily dose) and titrated slowly upward with careful monitoring, as its complex pharmacokinetics and long half-life create significant risk of accumulation and delayed toxicity despite its short analgesic duration of only 6-8 hours, according to the National Comprehensive Cancer Network 1, 2
Deaths have occurred during early treatment due to cumulative effects over the first several days, as methadone accumulates in tissues before reaching steady-state at 3-5 days, highlighting the need for careful monitoring and dosing, as recommended by the National Comprehensive Cancer Network 1

The analgesic effect of methadone lasts only 6-8 hours despite the 30+ hour half-life, requiring dosing every 6-8 hours for pain control, not once daily, as stated by the Clinical Infectious Diseases guidelines 3, 2
Split-dosing (dividing total daily dose into 3-4 administrations) is strongly recommended to maintain continuous pain control, according to the Clinical Infectious Diseases guidelines 3
Once-daily dosing is appropriate only for opioid use disorder treatment, not pain management, as noted by the Clinical Infectious Diseases guidelines 2

The National Comprehensive Cancer Network recommends obtaining baseline ECG before initiation of methadone and follow-up ECG required for doses >100 mg daily, patients with cardiac disease, or those on QTc-prolonging medications, due to the risk of QTc prolongation and torsades de pointes 1, 4
QTc ≥450 ms indicates need to reduce or discontinue methadone, as recommended by the National Comprehensive Cancer Network 1
High doses (≥120 mg) significantly increase risk of torsades de pointes and sudden cardiac death, highlighting the need for careful dosing and monitoring, as stated by the National Comprehensive Cancer Network 1, 4

The National Comprehensive Cancer Network strongly advises consulting pain specialists for providers unfamiliar with methadone prescribing, due to the complex, non-linear conversion ratios from other opioids and high interpatient variability in pharmacokinetics 1, 4
The National Comprehensive Cancer Network recommends avoiding standard equianalgesic tables, as the morphine-to-methadone ratio is not fixed and becomes increasingly favorable to methadone at higher morphine doses, and avoiding rapid titration, as it can lead to iatrogenic overdose 1